Soda Health vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Soda Health logo

Soda Health

EmergingHealthcare

Supplemental Health Benefits Administration & Health Equity Platform

Soda Health is a healthcare technology platform managing supplemental benefits (OTC, food, fitness, flex cards) for Medicare Advantage and Medicaid members; bridges health plan payments with retail and service providers to reduce health inequity;

About

Soda Health is a healthcare technology company founded in 2020 and headquartered in Atlanta, Georgia, that operates a supplemental benefits administration platform for health insurers — primarily Medicare Advantage and Medicaid plans. As health plans increasingly offer non-medical supplemental benefits (such as over-the-counter health product allowances, food and produce benefits, fitness memberships, and flexible spending cards) to address social determinants of health, Soda Health's platform manages the administration, member experience, and retail fulfillment of these benefits. The platform bridges the gap between health plan benefit design and the retail and service network where members actually use their benefits — simplifying what has historically been a fragmented, confusing experience for vulnerable populations.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

Key Details

Category
Supplemental Health Benefits Administration & Health Equity Platform
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.